ArticleESMO open2020

Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma.

Patrick Yung Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.